ArticleMolecular cancer research : MCR2023

ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.

Alexandra McMellen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.